Bone marrow cells recruited through the neuropilin-1 receptor promote arterial formation at the sites of adult neoangiogenesis in mice

Journal of Clinical Investigation

Volumn 118, Issue 6, 2008, Pages 2062-2075

  Zacchigna, Serena ^a   Pattarini, Lucia ^a   Zentilin, Lorena ^a   Moimas, Silvia ^a   Carrer, Alessandro ^a   Sinigaglia, Milena ^a   Arsic, Nikola ^a   Tafuro, Sabrina ^a   Sinagra, Gianfranco ^b   Giacca, Mauro ^a,b  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROPILIN 1; PARVOVIRUS VECTOR; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CELL ACTIVATION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN BINDING; VASCULARIZATION;

ANIMALS; ANTIGENS, CD11B; ANTIGENS, CD31; ARTERIES; BONE MARROW CELLS; CELL PROLIFERATION; DEPENDOVIRUS; GENE EXPRESSION REGULATION; GENE THERAPY; MICE; NEOVASCULARIZATION, PATHOLOGIC; NEUROPILIN-1; SEMAPHORIN-3A; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 45749092525     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI32832     Document Type: Article

References (53)

1. Ferrara, N., Gerber, H.P., and LeCouter, J. 2003. The biology of VEGF and its receptors. Nat. Med. 9:669-676.
2. Carmeliet, P. 2005. Angiogenesis in life, disease and medicine. Nature. 438:932-936.
3. Carmeliet, P., et al. 1999. Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nat. Med. 5:495-502.
4. Mattot, V., et al. 2002. Loss of the VEGF(164) and VEGF(188) isoforms impairs postnatal glomerular angiogenesis and renal arteriogenesis in mice. J. Am. Soc. Nephrol. 13:1548-1560.
5. Stalmans, I., et al. 2002. Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. J. Clin. Invest. 109:327-336.
6. Miao, H.Q., et al. 1999. Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165. J. Cell Biol. 146:233-242.
7. Jia, H., et al. 2006. Characterization of a bicyclic peptide neuropilin-1 (NP-1) antagonist (EG3287) reveals importance of vascular endothelial growth factor exon 8 for NP-1 binding and role of NP-1 in KDR Signaling. J. Biol. Chem. 281:13493-13502.
8. Soker, S., Takashima, S., Miao, H.Q., Neufeld, G., and Klagsbrun, M. 1998. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform- specific receptor for vascular endothelial growth factor. Cell. 92:735-745.
9. Kolodkin, A.L., et al. 1997. Neuropilin is a semaphorin III receptor. Cell. 90:753-762.
10. Kawasaki, T., et al. 1999. A requirement for neuropilin-1 in embryonic vessel formation. Development. 126:4895-4902.
11. Kitsukawa, T., Shimono, A., Kawakami, A., Kondoh, H., and Fujisawa, H. 1995. Overexpression of a membrane protein, neuropilin, in chimeric mice causes anomalies in the cardiovascular system, nervous system and limbs. Development. 121:4309-4318.
12. Rafii, S. 2000. Circulating endothelial precursors: mystery, reality, and promise. J. Clin. Invest. 105:17-19.
13. Urbich, C., and Dimmeler, S. 2004. Endothelial progenitor cells: characterization and role in vascular biology. Circ. Res. 95:343-353.
14. Ziegelhoeffer, T., et al. 2004. Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ. Res. 94:230-238.
15. Wagers, A.J., Sherwood, R.I., Christensen, J.L., and Weissman, I.L. 2002. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science. 297:2256-2259.
16. Rosenzweig, A. 2006. Cardiac cell therapy - mixed results from mixed cells. N. Engl. J. Med. 355:1274-1277.
17. Heil, M., et al. 2004. Collateral artery growth (arteriogenesis) after experimental arterial occlusion is impaired in mice lacking CC-chemokine receptor-2. Circ. Res. 94:671-677.
18. Arras, M., et al. 1998. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J. Clin. Invest. 101:40-50.
19. Imada, T., et al. 2005. Targeted delivery of bone marrow mononuclear cells by ultrasound destruction of microbubbles induces both angiogenesis and arteriogenesis response. Arterioscler. Thromb. Vasc. Biol. 25:2128-2134.
20. Hoefer, I.E., et al. 2005. Leukocyte subpopulations and arteriogenesis: specific role of monocytes, lymphocytes and granulocytes. Atherosclerosis. 181:285-293.
21. Dor, Y., et al. 2002. Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy. EMBO J. 21:1939-1947.
22. Grunewald, M., et al. 2006. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell. 124:175-189.
23. Arsic, N., et al. 2003. Induction of functional neovascularization by combined VEGF and angiopoietin-1 gene transfer using AAV vectors. Mol. Ther. 7:450-459.
24. Springer, M.L., et al. 2003. Localized arteriole formation directly adjacent to the site of VEGF-induced angiogenesis in muscle. Mol. Ther. 7:441-449.
25. Zentilin, L., et al. 2006. Bone marrow mononuclear cells are recruited to the sites of VEGF-induced neovascularization but are not incorporated into the newly formed vessels. Blood. 107:3546-3554.
26. Zacchigna, S., et al. 2005. Improved survival of ischemic cutaneous and musculocutaneous flaps after vascular endothelial growth factor gene transfer using adeno-associated virus vectors. Am. J. Pathol. 167:981-991.
27. Ferrarini, M., et al. 2006. Adeno-associated virus-mediated transduction of VEGF165 improves cardiac tissue viability and functional recovery after permanent coronary occlusion in conscious dogs. Circ. Res. 98:954-961.
28. Neufeld, G., Cohen, T., Gengrinovitch, S., and Poltorak, Z. 1999. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13:9-22.
29. Gowdak, L.H., et al. 2000. Adenovirus-mediated VEGF(121) gene transfer stimulates angiogenesis in normoperfused skeletal muscle and preserves tissue perfusion after induction of ischemia. Circulation. 102:565-571.
30. Rajagopalan, S., Shah, M., Luciano, A., Crystal, R., and Nabel, E.G. 2001. Adenovirus-mediated gene transfer of VEGF(121) improves lower-extremity endothelial function and flow reserve. Circulation. 104:753-755.
31. Rosengart, T.K., et al. 1999. Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation. 100:468-474.
32. Springer, M.L., Chen, A.S., Kraft, P.E., Bednarski, M., and Blau, H.M. 1998. VEGF gene delivery to muscle: potential role for vasculogenesis in adults. Mol. Cell. 2:549-558.
33. Pan, Q., et al. 2007. Neuropilin-1 binds to VEGF121 and regulates endothelial cell migration and sprouting. J. Biol. Chem. 282:24049-24056.
34. Serini, G., et al. 2003. Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function. Nature. 424:391-397.
35. Acevedo, L.M., Barillas, S., Weis, S.M., Gothert, J.R., and Cheresh, D.A. 2008. Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor. Blood. 111:2674-2680.
36. De Palma, M., Venneri, M.A., Roca, C., and Naldini, L. 2003. Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nat. Med. 9:789-795.
37. Rajantie, I., et al. 2004. Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells. Blood. 104:2084-2086.
38. Song, S., Ewald, A.J., Stallcup, W., Werb, Z., and Bergers, G. 2005. PDGFRbeta+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival. Nat. Cell Biol. 7:870-879.
39. Hirschi, K.K., Rohovsky, S.A., and D'Amore, P.A. 1998. PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J. Cell Biol. 141:805-814.
40. Leveen, P., et al. 1994. Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev. 8:1875-1887.
41. Suri, C., et al. 1996. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell. 87:1171-1180.
42. Hirschi, K.K., Rohovsky, S.A., Beck, L.H., Smith, S.R., and D'Amore, P.A. 1999. Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth factor-Bb and heterotypic cell contact. Circ. Res. 84:298-305.
43. Heil, M., and Schaper, W. 2004. Influence of mechanical, cellular, and molecular factors on collateral artery growth (arteriogenesis). Circ. Res. 95:449-458.
44. Hoefer, I.E., et al. 2004. Arteriogenesis proceeds via ICAM-1/Mac-1- mediated mechanisms. Circ. Res. 94:1179-1185.
45. Ito, W.D., et al. 1997. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ. Res. 80:829-837.
46. Strauer, B.E., et al. 2002. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation. 106:1913-1918.
47. Perin, E.C., et al. 2003. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation. 107:2294-2302.
48. Stamm, C., et al. 2003. Autologous bone-marrow stemcell transplantation for myocardial regeneration. Lancet. 361:45-46.
49. Perin, E.C., et al. 2004. Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation. 110:II213-II218.
50. Yaoita, H., et al. 2005. Scintigraphic assessment of the effects of bone marrow-derived mononuclear cell transplantation combined with off-pump coronary artery bypass surgery in patients with ischemic heart disease. J. Nucl. Med. 46:1610-1617.
51. Todorovic, V., et al. 2005. Human origins of DNA replication selected from a library of nascent DNA. Mol. Cell. 19:567-575.
52. Miles, A.A., and Miles, E.M. 1952. Vascular reaction to histamine, histamine-liberator, and leukotaxine in the skin of guinea pigs. J. Physiol. 118:228-257.
53. Elbashir, S.M., Harborth, J., Weber, K., and Tuschl, T. 2002. Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods. 26:199-213.